Overview of HIV : Psychosomatic Medicine

Journal Logo

HIV Overview

Overview of HIV

Klimas, Nancy MD; Koneru, Anne O’Brien MSN, ARNP; Fletcher, Mary Ann PhD

Author Information
Psychosomatic Medicine 70(5):p 523-530, June 2008. | DOI: 10.1097/PSY.0b013e31817ae69f

Abstract

This article provides an overview and reviews the HIV pandemic, the basic biology and immunology of the virus (e.g., genetic diversity of HIV and the viral life cycle), the phases of disease progression, modes of HIV transmission, HIV testing, immune response to the infection, and current therapeutic strategies. HIV is occurring in epidemic proportions, especially in Sub-Saharan Africa. In the US, men who have sex with men account for over half of AIDS diagnoses; racial and ethnic minorities are disproportionally affected. Factors influencing the progression and severity of HIV infection include type of immune response, coinfection (e.g., another sexually transmitted infection, including hepatitis B or C), age and behavioral and psychosocial factors. Antiretroviral therapies can achieve reduction in blood levels of the HIV virus below the limits of detection by current technology. However, effective treatment requires adherence to therapy. Patient failure to adhere to treatment regimens results in detectible circulating virus and in HIV disease progression, and is the primary cause of drug resistance. In addition to research on the immunology and virology of the disease, other studies focus on behavioral and psychosocial factors that may affect medication adherence and risk behaviors.

CDC = Centers for Disease Control and Prevention;

PCP = Pneumocystis carinii pneumonia;

HCV = hepatitis C virus;

ART = antiretroviral treatment;

HAART = highly active antiretroviral therapy.

Copyright © 2008 by American Psychosomatic Society

You can read the full text of this article if you:

Access through Ovid